Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma

Kalow, 1957, On distribution and inheritance of atypical forms of human serum cholinesterase, as indicated by dibucaine numbers, Can J Med Sci, 35, 1305 Kalow, 1995, vol. I Souza, 2005, Four new mutations in the BCHE gene of human butyrylcholinesterase in a Brazilian blood donor sample, Mol Genet Metab, 84, 349, 10.1016/j.ymgme.2004.12.005 Abbott, 1993, Relationship between serum butyrylcholinesterase activity, hypertriglyceridaemia and insulin sensitivity in diabetes mellitus, Clin Sci (Lond), 85, 77, 10.1042/cs0850077 Cucuianu, 2002, Serum cholinesterase activity correlates with serum insulin, C-peptide and free fatty acids levels in patients with type 2 diabetes, Rom J Intern Med, 40, 43 Alcantara, 2002, Butyrylcholinesterase activity and risk factors for coronary artery disease, Scand J Clin Lab Invest, 62, 399, 10.1080/00365510260296564 Gesztes, 1966, Prolonged apnoea after suxamethonium injection associated with eye drops containing an anticholinesterase agent, Br J Anaesth, 38, 408, 10.1093/bja/38.5.408 McGehee, 2000, Cholinesterase inhibition by potato glycoalkaloids slows mivacurium metabolism, Anesthesiology, 93, 510, 10.1097/00000542-200008000-00031 Means, 1979, The reactive tyrosine residue of human serum albumin: characterization of its reaction with diisopropylfluorophosphate, Arch Biochem Biophys, 194, 526, 10.1016/0003-9861(79)90647-7 Sakurai, 2004, Esterase-like activity of serum albumin: characterization of its structural chemistry using p-nitrophenyl esters as substrates, Pharm Res, 21, 285, 10.1023/B:PHAM.0000016241.84630.06 Watanabe, 2000, Role of arg-410 and tyr-411 in human serum albumin for ligand binding and esterase-like activity, Biochem J, 349, 813, 10.1042/bj3490813 Hagag, 1983, Resonance energy transfer between cysteine-34, tryptophan-214, and tyrosine-411 of human serum albumin, Biochemistry, 22, 2420, 10.1021/bi00279a018 Tove, 1962, The esterolytic activity of serum albumin, Biochim Biophys Acta, 57, 230, 10.1016/0006-3002(62)91115-0 Awad-Elkarim, 1988, The reactivity of p-nitrophenyl acetate with serum albumins, Comp Biochem Physiol B, 91, 267, 10.1016/0305-0491(88)90141-1 Ahmed, 2005, Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity, J Biol Chem, 280, 5724, 10.1074/jbc.M410973200 Salvi, 1997, Esterase-like activity of human serum albumin toward prodrug esters of nicotinic acid, Drug Metab Dispos, 25, 395 Sogorb, 1998, Phosphotriesterase activity identified in purified serum albumins, Arch Toxicol, 72, 219, 10.1007/s002040050492 Erdos, 1961, Hydrolysis of paraoxon in mammalian blood, Nature, 190, 716, 10.1038/190716a0 Yoshida, 1985, Esterase-like activity of human serum albumin. V. Reaction with 2,4-dinitrophenyl diethyl phosphate, Chem Pharm Bull (Tokyo), 33, 4995, 10.1248/cpb.33.4995 Kragh-Hansen, 2002, Practical aspects of the ligand-binding and enzymatic properties of human serum albumin, Biol Pharm Bull, 25, 695, 10.1248/bpb.25.695 Sanger, 1963, Amino acid sequences in the active centers of certain enzymes, Proc Chem Soc, 5, 76 Schopfer, 2005, Characteristic mass spectral fragments of the organophosphorus agent FP-biotin and FP-biotinylated peptides from trypsin and bovine albumin (Tyr 410), Anal Biochem, 345, 122, 10.1016/j.ab.2005.07.016 Duysen, 2002, Rescue of the acetylcholinesterase knockout mouse by feeding a liquid diet: phenotype of the adult acetylcholinesterase deficient mouse, Brain Res Dev Brain Res, 137, 43, 10.1016/S0165-3806(02)00367-X Li B, Duysen EG, Saunders TL, Lockridge O. Production of the butyrylcholinesterase knockout mouse. Adv Exp Med Biol. Lockridge, 2005, Large scale purification of butyrylcholinesterase from human plasma suitable for injection into monkeys: a potential new therapeutic for protection against cocaine and nerve agent toxicity, J Med Chem Biol Radiol Defense, 3 Karnovsky, 1964, J Histochem Cytochem, 12, 219, 10.1177/12.3.219 Furlong, 1991, Purification of rabbit and human serum paraoxonase, Biochemistry, 30, 10133, 10.1021/bi00106a009 Hashinotsume, 1978, Purification and enzymatic properties of rat serum carboxylesterase, J Biochem (Tokyo), 84, 1325, 10.1093/oxfordjournals.jbchem.a132254 Maxwell, 1994, Oxime-induced reactivation of carboxylesterase inhibited by organophosphorus compounds, Chem Res Toxicol, 7, 428, 10.1021/tx00039a022 Peeples, 2005, Albumin, a new biomarker of organophosphorus toxicant exposure, identified by mass spectrometry, Toxicol Sci, 83, 303, 10.1093/toxsci/kfi023 Ellman, 1961, A new and rapid colorimetric determination of acetylcholinesterase activity, Biochem Pharmacol, 7, 88, 10.1016/0006-2952(61)90145-9 Ecobichon, 1962, Properties and classification of the soluble esterases of human liver, Biochem Pharmacol, 11, 573, 10.1016/0006-2952(62)90118-1 Casida, 1959, Reaction of plasma albumin with 1-naphthyl N-methylcarbamate and certain other esters, Biochim Biophys Acta, 36, 411, 10.1016/0006-3002(59)90184-2 Hess, 1963, Proteins and isozymes of esterases and cholinesterases from sera of different species, Clin Chim Acta, 19, 656, 10.1016/0009-8981(63)90127-X Brimijoin, 1988, Butyrylcholinesterase in human brain and acetylcholinesterase in human plasma: trace enzymes measured by two-site immunoassay, J Neurochem, 51, 1227, 10.1111/j.1471-4159.1988.tb03091.x Sorensen, 1986, Normal human serum contains two forms of acetylcholinesterase, Clin Chim Acta, 158, 1, 10.1016/0009-8981(86)90109-9 Saez-Valero, 1993, Amphiphilic and hydrophilic forms of acetyl- and butyrylcholinesterase in human brain, J Neurosci Res, 35, 678, 10.1002/jnr.490350610 Simpson, 1972, Polyacrylamide electrophoresis used for the detection of C5+ cholinesterase in Canadian Caucasians, Indians, and Eskimos, Am J Hum Genet, 24, 317 Saxena, 2003, Natural monomeric form of fetal bovine serum acetylcholinesterase lacks the C-terminal tetramerization domain, Biochemistry, 42, 15292, 10.1021/bi030150x Matsubara, 1984, Spontaneous reactivation of mouse plasma cholinesterase after inhibition by various organophosphorus compounds, J Pharmacobiodyn, 7, 322, 10.1248/bpb1978.7.322 Kaliste-Korhonen, 1996, Interspecies differences in enzymes reacting with organophosphates and their inhibition by paraoxon in vitro, Hum Exp Toxicol, 15, 972, 10.1177/096032719601501205 Quistad, 2005, Blood acylpeptide hydrolase activity is a sensitive marker for exposure to some organophosphate toxicants, Toxicol Sci, 86, 291, 10.1093/toxsci/kfi195 Anderson, 2004, The human plasma proteome: a nonredundant list developed by combination of four separate sources, Mol Cell Proteomics, 3, 311, 10.1074/mcp.M300127-MCP200 Muthusamy, 2005, Plasma proteome database as a resource for proteomics research, Proteomics, 5, 3531, 10.1002/pmic.200401335 Guemei, 2001, Human plasma carboxylesterase and butyrylcholinesterase enzyme activity: correlations with SN-38 pharmacokinetics during a prolonged infusion of irinotecan, Cancer Chemother Pharmacol, 47, 283, 10.1007/s002800000258 Shirai, 1985, Human plasma carboxyl esterase-catalyzed triolein hydrolysis. Existence of promoting factor in serum, J Biol Chem, 260, 5225, 10.1016/S0021-9258(18)89007-X Shirai, 1988, Effects of phospholipids on hydrolysis of trioleoylglycerol by human serum carboxylesterase, Biochim Biophys Acta, 962, 377, 10.1016/0005-2760(88)90268-8 Satoh, 1998, The mammalian carboxylesterases: from molecules to functions, Annu Rev Pharmacol Toxicol, 38, 257, 10.1146/annurev.pharmtox.38.1.257 Albers, 1969, Allotypes and isozymes of rabbit alpha-1-aryl esterase. Allelic products with different enzymatic acitivities for the same substrates, Biochemistry, 8, 4416, 10.1021/bi00839a029 Aldridge, 1953, Two types of esterase (A and B) hydrolysing p-nitrophenyl acetate, propionate and butyrate, and a method for their determination, Biochem J, 53, 110, 10.1042/bj0530110 Smolen, 1991, Characteristics of the genetically determined allozymic forms of human serum paraoxonase/arylesterase, Drug Metab Dispos, 19, 107 Leng, 1999, The influence of individual susceptibility in pyrethroid exposure, Toxicol Lett, 107, 123, 10.1016/S0378-4274(99)00039-9 Morton CL, Iacono L, Hyatt JL, Taylor KR, Cheshire PJ, Houghton PJ, et al. Activation and antitumor activity of CPT-11 in plasma esterase-deficient mice. Cancer Chemother Pharmacol 2005; in press. Augustinsson, 1961, Multiple forms of esterase in vertebrate blood plasma, Ann NY Acad Sci, 94, 844, 10.1111/j.1749-6632.1961.tb35578.x Maxwell, 1987, The effect of carboxylesterase inhibition on interspecies differences in soman toxicity, Toxicol Lett, 39, 35, 10.1016/0378-4274(87)90254-2 Quon, 1985, Biochemical properties of blood esmolol esterase, Drug Metab Dispos, 13, 420 Kusumoto, 1988, Human genes for complement components C1r and C1s in a close tail-to-tail arrangement, Proc Natl Acad Sci USA, 85, 7307, 10.1073/pnas.85.19.7307 Masson, 1998, Butyrylcholinesterase-catalysed hydrolysis of aspirin, a negatively charged ester, and aspirin-related neutral esters, Biochim Biophys Acta, 1387, 41, 10.1016/S0167-4838(98)00104-6 Rainsford, 1980, Plasma aspirin esterases in normal individuals, patients with alcoholic liver disease and rheumatoid arthritis: characterization and the importance of the enzymic components, Eur J Clin Invest, 10, 413, 10.1111/j.1365-2362.1980.tb00054.x Morikawa, 1979, Studies on aspirin esterase of human serum, Jpn J Pharmacol, 29, 581, 10.1254/jjp.29.581 Gilmer, 2002, Isosorbide-based aspirin prodrugs. II. Hydrolysis kinetics of isosorbide diaspirinate, Eur J Pharm Sci, 16, 297, 10.1016/S0928-0987(02)00124-0 Tunek, 1988, Bambuterol, a carbamate ester prodrug of terbutaline, as inhibitor of cholinesterases in human blood, Drug Metab Dispos, 16, 759 Stewart, 1977, Hydrolysis of cocaine in human plasma by cholinesterase, Life Sci, 20, 1557, 10.1016/0024-3205(77)90448-9 Lynch, 1997, Cocaine detoxification by human plasma butyrylcholinesterase, Toxicol Appl Pharmacol, 145, 363, 10.1006/taap.1997.8187 Morton, 1999, The anticancer prodrug CPT-11 is a potent inhibitor of acetylcholinesterase but is rapidly catalyzed to SN-38 by butyrylcholinesterase, Cancer Res, 59, 1458 Quon, 1993, Biochemical characterization of flestolol esterase, Res Commun Chem Pathol Pharmacol, 81, 309 Chapuis, 2001, The esterase-like activity of serum albumin may be due to cholinesterase contamination, Pharm Res, 18, 1435, 10.1023/A:1012204906502 De Vriese, 2004, Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites, Endocrinology, 145, 4997, 10.1210/en.2004-0569 Lockridge, 1980, Hydrolysis of diacetylmorphine (heroin) by human serum cholinesterase, J Pharmacol Exp Ther, 215, 1 Foldes, 1953, Substrate competition procaine and succinylcholine diiodide for plasma cholinesterase, Science, 117, 383, 10.1126/science.117.3041.383 Lockridge, 1990, Genetic variants of human serum cholinesterase influence metabolism of the muscle relaxant succinylcholine, Pharmacol Ther, 47, 35, 10.1016/0163-7258(90)90044-3 Ostergaard, 1995, Dose–response relationship for mivacurium in patients with phenotypically abnormal plasma cholinesterase activity, Acta Anaesthesiol Scand, 39, 1016, 10.1111/j.1399-6576.1995.tb04220.x Savarese, 1988, The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug, Anesthesiology, 68, 723, 10.1097/00000542-198805000-00010 Meyers, 1982, Hydrolysis of methylprednisolone acetate by human serum cholinesterase, Drug Metab Dispos, 10, 279 O’Brien, 1979, Metabolism and measurement of chloroprocaine, an ester-type local anesthetic, J Pharm Sci, 68, 75, 10.1002/jps.2600680123 Becker, 1973, Cholinesterase genotype and hydrolysis of choline esters, procaine and tetracaine, Hum Hered, 23, 394, 10.1159/000152603 Billecke, 2000, Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters, Drug Metab Dispos, 28, 1335 Ortigoza-Ferado, 1984, Paraoxon hydrolysis in human serum mediated by a genetically variable arylesterase and albumin, Am J Hum Genet, 36, 295 Davies, 1996, The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin, Nat Genet, 14, 334, 10.1038/ng1196-334 Tougou, 1998, Paraoxonase has a major role in the hydrolysis of prulifloxacin (NM441), a prodrug of a new antibacterial agent, Drug Metab Dispos, 26, 355 Biggadike, 2000, Selective plasma hydrolysis of glucocorticoid gamma-lactones and cyclic carbonates by the enzyme paraoxonase: an ideal plasma inactivation mechanism, J Med Chem, 43, 19, 10.1021/jm990436t Kiderlen, 2005, Formation and disposition of diethylphosphoryl-obidoxime, a potent anticholinesterase that is hydrolyzed by human paraoxonase (PON1), Biochem Pharmacol, 69, 1853, 10.1016/j.bcp.2005.04.003 Agarwal, 1986, Serum albumin and the metabolism of disulfiram, Biochem Pharmacol, 35, 3341, 10.1016/0006-2952(86)90433-8 Kwon, 1987, Accelerated decomposition of 4-hydroxycyclophosphamide by human serum albumin, Cancer Res, 47, 1505 Dubois-Presle, 1995, Stereoselective esterase activity of human serum albumin toward ketoprofen glucuronide, Mol Pharmacol, 47, 647 Sogorb, 2004, Hydrolysis of carbaryl by human serum albumin, Arch Toxicol, 78, 629, 10.1007/s00204-004-0584-x Gan, 1991, Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities, Drug Metab Dispos, 19, 100 Blatter Garin, 1994, Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations, Biochem J, 304, 549, 10.1042/bj3040549 Oda, 2002, Paraoxonase 1 overexpression in mice and its effect on high-density lipoproteins, Biochem Biophys Res Commun, 290, 921, 10.1006/bbrc.2001.6295 Peters, 1996 Lexow, 1980, Purification and characterization of esterase 2B of the house mouse, Mus musculus, Eur J Biochem, 107, 123, 10.1111/j.1432-1033.1980.tb04632.x Masson, 1989, A naturally occurring molecular form of human plasma cholinesterase is an albumin conjugate, Biochim Biophys Acta, 998, 258, 10.1016/0167-4838(89)90282-3